Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
Katherine E. Wright(Memorial Hermann), Matthew K. Higgins(University of Oxford), Willem A. de Jongh(ExpreS2ion Biotechnologies (Denmark)), Joseph J. Illingworth(University of Oxford), Simon J. Draper(University of Oxford), Jonathan D. Bartlett(Manchester Metropolitan University), Kathryn A. Hjerrild(Research & Development Corporation), Rebecca E. Brown(Tufts University), Alexander D. Douglas(University of Oxford), Rebecca Ashfield(Immunocore (United Kingdom)), Jing Jin(Guangdong Province Women and Children Hospital), Stine B. Clemmensen(ExpreS2ion Biotechnologies (Denmark))
Cited by 241
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Severe malaria is associated with parasite binding to endothelial protein C receptor
|Nature|2013|579
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
|Scientific Reports|2016|438